Artificial intelligence enhances whole‐slide interpretation of PD‐L1 CPS in triple‐negative breast cancer: A multi‐institutional ring study

Abstract

Background and aimsEvaluation of the programmed cell death ligand‐1 (PD‐L1) combined positive score (CPS) is vital to predict the efficacy of the immunotherapy in triple‐negative breast cancer (TNBC), but pathologists show substantial variability in the consistency and accuracy of the interpretation. It is of great importance to establish an objective and effective method which is highly repeatable.MethodsWe proposed a model in a deep learning‐based framework, which at the patch level incorporated cell analysis and tissue region analysis, followed by the whole‐slide level fusion of patch results. Three rounds of ring studies (RSs) were conducted. Twenty‐one pathologists of different levels from four institutions evaluated the PD‐L1 CPS in TNBC specimens as continuous scores by visual assessment and our artificial intelligence (AI)‐assisted method.ResultsIn the visual assessment, the interpretation results of PD‐L1 (Dako 22C3) CPS by different levels of pathologists have significant differences and showed weak consistency. Using AI‐assisted interpretation, there were no significant differences between all pathologists (P = 0.43), and the intraclass correlation coefficient (ICC) value was increased from 0.618 [95% confidence interval (CI) = 0.524–0.719] to 0.931 (95% CI = 0.902–0.955). The accuracy of interpretation result is further improved to 0.919 (95% CI = 0.886–0.947). Acceptance of AI results by junior pathologists was the highest among all levels, and 80% of the AI results were accepted overall.ConclusionWith the help of the AI‐assisted diagnostic method, different levels of pathologists achieved excellent consistency and repeatability in the interpretation of PD‐L1 (Dako 22C3) CPS. Our AI‐assisted diagnostic approach was proved to strengthen the consistency and repeatability in clinical practice.